Interferon-β or azathioprine as add-on therapies in patients with active multiple sclerosis.
about
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.The inhibin-βC subunit is down-regulated, while inhibin-βE is up-regulated by interferon-β1a in Ishikawa carcinoma cell line.Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.
P2860
Interferon-β or azathioprine as add-on therapies in patients with active multiple sclerosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@en
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@nl
type
label
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@en
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@nl
prefLabel
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@en
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@nl
P2860
P1476
Interferon-β or azathioprine a ...... ith active multiple sclerosis.
@en
P2093
Eva Havrdova
Veronika Ticha
P2860
P304
P356
10.1179/1743132812Y.0000000090
P577
2012-08-21T00:00:00Z